FedInvent™ Patents

Patent Details for Tuesday, January 18, 2011 

This page was updated on Monday, March 27, 2023 at 01:57 AM GMT

Department of Defense (DOD) 

US 07870737 Snyder
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
APPLICANT(S)
ASSIGNEE(S) United Technologies Corporation (Hartford, Connecticut)
INVENTOR(S) Timothy S. Snyder (Glastonbury, Connecticut)
ABSTRACT A gas turbine engine pilot assembly includes a swirler having high and low pressure sides. A hood at least partially encloses the swirler on the high pressure side. The hood is secured over the swirler, in one example. The hood includes an aperture creating a tortuous path from the high pressure side to the low pressure side through the swirler. The hood reduces the differential pressure across the swirler by reducing the velocity and pressure of the air before entering the swirler. In one example, the hood includes first and second spaced apart walls interconnected by a perimeter wall. The walls form a generally annular structure, in one example. At least one of the walls includes an array of apertures communicating with a cavity interiorly arranged within the walls upstream from the swirler. Air from the high pressure side flows through the apertures and is slowed before passing through the swirler and into a combustion chamber.
FILED Thursday, April 05, 2007
APPL NO 11/696766
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Power plants
060/748
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07870741 Corsmeier et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
APPLICANT(S)
ASSIGNEE(S) General Electric Company (Schenectady, New York)
INVENTOR(S) Donald Michael Corsmeier (West Chester, Ohio);  David Lynn Dawson (Liberty Township, Ohio)
ABSTRACT A method of assembling a crank assembly for a turbine engine. The turbine engine includes a valve assembly including an outer fairing and an inner fairing coupled to the outer fairing with a strut. The valve assembly further includes an annular slide valve coupled between the inner and outer fairings. The valve assembly is positioned within a duct having a radially outer duct wall and a radially inner duct wall. The method includes coupling a first arm of a crank assembly to the annular slide valve, and coupling a second arm of the crank assembly to the outer fairing such that the crank assembly controls movement of the annular slide valve and for moving the outer and inner fairings between a first operational position and a second operational position to facilitate regulating an amount of airflow channeled through the turbine engine.
FILED Friday, May 25, 2007
APPL NO 11/753907
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Power plants
060/770
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07870816 Willingham et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S)
ASSIGNEE(S) Lockheed Martin Corporation (Bethesda, Maryland)
INVENTOR(S) Michael R. Willingham (Fort Worth, Texas);  Robert J. McCarty, Jr. (Plano, Texas)
ABSTRACT In a first aspect, an automated method for engaging a target comprises: slewing a weapon to an estimated target state; and aligning the weapon's boresight with the actual target state. Aligning the weapon's boresight with the actual target state includes designating the target to obtain the actual target state; and zeroing an offset between the actual target state and the estimated target state. In a second aspect, an apparatus, comprises: means for slewing a weapon to an estimated target state; and means aligning the weapon's boresight with the actual target state. The aligning means includes designating the target to obtain the actual target state; and zeroing an offset between the actual target state and the estimated target state. In a third aspect, a weapon system comprises: a targeting sensor capable of designating a target; a weapon; and an alignment sensor associated with the weapon, and capable of receiving the designation and aligning the weapon's boresight with the designated target. In a fourth aspect, a laser rangefinder, comprises: a laser designator capable of designating a target from an estimated target state; and a quad cell detector capable of receiving the designation.
FILED Thursday, July 26, 2007
APPL NO 11/828815
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Ordnance
089/204
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871021 Cooke
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S)
ASSIGNEE(S) Delphi Technologies Holding S.arl (Troy, Michigan)
INVENTOR(S) Michael P. Cooke (Gillingham, United Kingdom)
ABSTRACT The invention relates to a fuel injection valve for internal combustion engines, comprising a valve body (1), with a drilling (3) embodied therein and defined at the combustion chamber end thereof by a conical valve seat (18) from which at least one injection opening (20) leads. A hollow valve needle (8) is arranged in the drilling (3) such as to be displaced longitudinally, comprising a valve sealing surface (35) at the end thereof facing the valve seat (18). A first sealing region (31; 34) and a second sealing region (32; 46; 48) are embodied on the valve sealing surface (35), whereby, on contact of the hollow valve needle (8) on the valve seat (18), the first sealing region (31; 34) provides a seal upstream of the at least one injection opening (20) and the second sealing region (32; 46; 48) downstream thereof.
FILED Tuesday, July 11, 2006
APPL NO 11/484504
ART UNIT 3752 — Fluid Handling and Dispensing
CURRENT CPC
Fluid sprinkling, spraying, and diffusing
239/533.200
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871044 Hursig et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S)
ASSIGNEE(S) Honeywell International Inc. (Morristown, New Jersey)
INVENTOR(S) David C. Hursig (Albuquerque, New Mexico);  Steven D. Martinez (Albuquerque, New Mexico)
ABSTRACT Takeoff and landing modes are added to a flight control system of a Vertical Take-Off and Landing (VTOL) Unmanned Air Vehicle (UAV). The takeoff and landing modes use data available to the flight control system and the VTOL UAV's existing control surfaces and throttle control. As a result, the VTOL UAV can takeoff from and land on inclined surfaces without the use of landing gear mechanisms designed to level the UAV on the inclined surfaces.
FILED Wednesday, May 23, 2007
APPL NO 11/752497
ART UNIT 3644 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeronautics and astronautics
244/183
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871106 Leonard et al.
FUNDED BY
Department of Defense (DOD)
United States Special Operations Command (SOCOM)
APPLICANT(S)
ASSIGNEE(S) Polaris Industries Inc. (Medina, Minnesota)
INVENTOR(S) Joshua J Leonard (North Branch, Minnesota);  Eric Bjerketvedt (North Branch, Minnesota);  Robert Bradley Morisch (Lindstrom, Minnesota);  Brian D Krosschell (Chisago, Minnesota);  James Bergman (Oslo, Minnesota);  Larry Holter (Alvarado, Minnesota);  Richard Nelson (Oslo, Minnesota);  Lionel Hoff (Oslo, Minnesota);  Doug Moman (Warren, Minnesota);  Mitchell D. Johnson (Roseau, Minnesota)
ABSTRACT A vehicle is disclosed. The vehicle may include a plurality of attachment devices to couple the vehicle to a harness. The vehicle may include a moveable roll cage which is moveable from a raised position to a lowered position.
FILED Monday, March 17, 2008
APPL NO 12/050041
ART UNIT 3616 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Land vehicles
280/756
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871242 Swanson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
APPLICANT(S)
ASSIGNEE(S) United Technologies Corporation (Hartford, Connecticut)
INVENTOR(S) Timothy A. Swanson (Coventry, Connecticut);  Carl T. Elving (Southlake, Texas);  Robert T. Brooks (Killingworth, Connecticut)
ABSTRACT A rotational flow balance system includes an actuator system which controls operation of both a fan duct blocker ring and a modulated exhaust cooling ring through a kinematic system. The kinematic system is controlled by the single actuator system such that the modulated exhaust cooling ring will remain in a fixed position while the fan duct blocker ring can be moved to satisfy operational requirements.
FILED Thursday, May 31, 2007
APPL NO 11/755925
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Rotary kinetic fluid motors or pumps
415/145
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871247 Shah et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
APPLICANT(S)
ASSIGNEE(S) United Technologies Corporation (Hartford, Connecticut)
INVENTOR(S) Dilip M. Shah (Glastonbury, Connecticut);  Alan D. Cetel (West Hartford, Connecticut);  Alan W. Stoner (Tullahoma, Tennessee);  William P. Allen (Plainfield, Illinois)
ABSTRACT A high modulus component, such as an aircraft engine turbine blade, is formed from a base metal that has a high modulus crystallographic orientation that is aligned with the primary, i.e. radial, direction of the turbine blade. The base metal is Ni, Fe, Ti, Co, Al, Nb, or Mo based alloy. Alignment of a high modulus direction of the base metal with the primary direction provides enhanced high cycle fatigue life.
FILED Friday, August 17, 2007
APPL NO 11/840330
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Fluid reaction surfaces
416/241.R00
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871248 Delaloye
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S)
ASSIGNEE(S) Honeywell International Inc. (Morristown, New Jersey)
INVENTOR(S) Jim E. Delaloye (Mesa, Arizona)
ABSTRACT A system for controlling lubricant displacement from a machine during turbomachine shutdown sequence includes a motor, a pump, a control valve, and a motor control unit. The motor is selectively energized from a power bus to rotate at a rotational speed and supply a drive force to the pump. The pump, in response to the drive force, draws fluid from a fluid and supplies the fluid to the machine. The control valve is movable between at least a first position, in which the control valve fluidly communicates the pump with a lubrication fluid source, and a second position, in which the control valve fluidly communicates the pump with a gaseous fluid source. During the shutdown sequence, the motor control unit controllably energizes the motor from the power bus to thereby control its rotational speed in accordance with a schedule that will displace at least a substantial volume of lubricant in the rotating machine with fluid from the gaseous fluid source.
FILED Tuesday, February 20, 2007
APPL NO 11/708727
ART UNIT 3746 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Pumps
417/28
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871459 Stephanopoulos et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S)
ASSIGNEE(S) Trustees of Tufts College (Boston, Massachusetts)
INVENTOR(S) Maria Flytzani Stephanopoulos (Winchester, Massachusetts);  Zheng Wang (Alexandria, Virginia);  Mann Sakbodin (Newbury Park, California)
ABSTRACT Disclosed is a doped cerium oxide sorbent that can effectively and regenerably remove H2S in the temperature range of about 500° C. to about 1000° C. Regenerable sorbents (e.g., ZnO, La2O3, CeO2) and methods of using them are disclosed that allow cyclic desulfurization from about 300-500° C., 350-450° C., and at about 400° C. In one embodiment, the present invention relates to a method of desulfurizing fuel gas comprising passing the fuel gas through the sorbent at a space velocity wherein the sulfur compounds are adsorbed substantially on the surface of the sorbent; and regenerating the sorbent by passing a regenerating gas through the sorbent, wherein substantially all of the sulfur compounds are desorbed from the sorbent surface. In a further embodiment, the method of desulfurizing fuel gas further comprises repeating the aforementioned steps while the fuel processor is in operation. In another embodiment, the step of passing the fuel gas may be preceded by reducing the sorbent by passing a reducing gas through the sorbent. In another embodiment, the sorbent may be fully sulfided, i.e., sulfided on its surface and bulk (internally).
FILED Tuesday, November 08, 2005
APPL NO 11/718864
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Gas separation: Processes
095/135
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871487 Wegner et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Peter M. Wegner (Tijeras, New Mexico);  Jeffrey M. Ganley (Albuquerque, New Mexico);  Brice A. Johnson (Federal Way, Washington);  Barry P. Van West (Bellevue, Washington)
ABSTRACT A method for fabricating a grid-stiffened structure from fiber-reinforced composite materials. Ribs are formed on a smooth hard base tool. Expansion blocks are placed in the shallow cavities formed by the ribs and the base tool, and held in place by one of several means while a skin is placed over the ribs, expansion blocks, and base tool. The assembly is then placed in a vacuum bag and autoclave cured. After cooling, the formed structure is separated from the base tool and the expansion blocks are removed from the cavities. This abstract is provided to comply with the rules requiring an abstract, and is intended to allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.
FILED Wednesday, December 10, 2008
APPL NO 12/332334
ART UNIT 1791 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Adhesive bonding and miscellaneous chemical manufacture
156/242
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871533 Haiping et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S)
ASSIGNEE(S) South Dakota School of Mines and Technology (Rapid City, South Dakota)
INVENTOR(S) Hong Haiping (Rapid City, South Dakota);  John Andrew Waynick (San Antonio, Texas)
ABSTRACT The present invention relates to compositions of a nanofluid, which comprises a thermal transfer fluid and carbon nanoparticles. The nanofluid may be hydrophilic nanofluids, such as a coolant, or hydrophobic nanofluids, such as nanolubricants or nanogreases. In particular, the present invention provides a homogenous hydrophilic nanofluid, which contains soluble carbon nanotubes in the hydrophilic thermal transfer fluid. The present invention also provides a nanogrease, which is a sustainable dispersion of solid carbon nanotubes in a hydrophobic thermal transfer fluid. The solid carbon nanotubes function as both as a thickener to modulate viscosity and as a solid heat transfer medium to enhance thermal conductivity and high temperature resistance.
FILED Friday, July 28, 2006
APPL NO 11/494954
ART UNIT 1796 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Compositions
252/70
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871663 Barnes et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Paul N. Barnes (West Milton, Ohio);  Joseph W. Kell (Kettering, Ohio);  Timothy J. Haugan (Beavercreek, Ohio)
ABSTRACT A method for enhancing the flux pinning of a YBCO superconductor by substituting minute quantities of rare earth elements (La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu) or other deleterious elements (Sc, etc.) for Y in YBCO thin films is described. The method of the present invention enables enhanced flux pinning of the material while not significantly increasing the cost of the HIS material and can be used in all HTS deposition methods since it is not process dependent.
FILED Tuesday, October 03, 2006
APPL NO 11/543286
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Coating processes
427/62
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871734 Hertz et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Joshua L. Hertz (Silver Spring, Maryland);  Harry L. Tuller (Wellesley Hills, Massachusetts)
ABSTRACT The present invention discloses a solid oxide fuel cell and method for fabricating solid oxide fuel cells using thin film processing techniques. The fuel cell comprises a cathode layer, an electrolyte layer, and an anode layer arranged in various configurations to optimize fuel cell performance.
FILED Wednesday, August 23, 2006
APPL NO 11/508752
ART UNIT 1795 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemistry: Electrical current producing apparatus, product, and process
429/479
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871796 Chen et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Missile Defense Agency (MDA)
APPLICANT(S)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Gang Chen (Austin, Texas);  Andrew Hayhurst (Austin, Texas);  Jeffrey G. Thomas (Bellevue, Washington);  Brent L. Iverson (Austin, Texas);  George Georgiou (Austin, Texas)
ABSTRACT The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides via “display-less” library screening. In the technique, libraries of candidate binding proteins, such as antibody sequences, are expressed in soluble form in the periplasmic space of gram negative bacteria, such as Escherichia coli, and are mixed with a labeled ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the concentration of the labeled ligand bound to the binding protein is increased and allows the cells to be isolated from the rest of the library. Where fluorescent labeling of the target ligand is used, cells may be isolated by fluorescence activated cell sorting (FACS). The approach is more rapid than prior art methods and avoids problems associated with the surface-expression of ligand fusion proteins employed with phage display.
FILED Tuesday, August 01, 2006
APPL NO 11/461757
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/69.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871833 Chow et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S)
ASSIGNEE(S) Oracle America, Inc. (Redwood Shores, California)
INVENTOR(S) Alex Chow (East Palo Alto, California);  Robert D. Hopkins (Hayward, California);  Justin M. Schauer (San Francisco, California)
ABSTRACT A semiconductor die includes proximity connectors proximate to a surface of the semiconductor die. This semiconductor die is configured to communicate signals with another semiconductor die via proximity communication through one or more of the proximity connectors. In particular, the proximity connectors include a first group of proximity connectors that is configured to facilitate determining a first separation between the semiconductor die and the other semiconductor die by comparing coupling capacitances between the semiconductor die and the other semiconductor die. Note that the first group of proximity connectors includes a first proximity connector and a second proximity connector, and the second proximity connector at least partially encloses an in-plane outer edge of the first proximity connector.
FILED Monday, November 09, 2009
APPL NO 12/615116
ART UNIT 2811 — Semiconductors/Memory
CURRENT CPC
Semiconductor device manufacturing: Process
438/14
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871978 Balian
FUNDED BY
Department of Defense (DOD)
APPLICANT(S)
ASSIGNEE(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
INVENTOR(S) Garabed Balian (Charlottesville, Virginia)
ABSTRACT The present invention is directed to the use of bone tropic peptides identified through the use of a phage display library. More particularly, the invention is directed to compositions comprising the bone tropic peptides and methods for using such compositions to regulate osteogenesis, cell adhesion and angiogenesis, and diseases and disorders thereof, and to inhibit cancer cell metastasis and growth.
FILED Friday, November 04, 2005
APPL NO 11/666940
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/5.900
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872027 Metallo et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S)
ASSIGNEE(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  Georgetown University (Washington, District of Columbia)
INVENTOR(S) Steven J. Metallo (Silver Springs, Maryland);  Edward V. Prochownik (Pittsburgh, Pennsylvania)
ABSTRACT Compounds and compositions for interfering with the association of Myc and Max are described herein. These compounds and compositions are useful in methods inhibiting growth or proliferation of a cell. Methods of inhibiting growth or proliferation of a cell are provided, comprising contacting the cell with an amount of a compound that interferes with Myc and Max association effective to inhibit growth or proliferation of the cell.
FILED Friday, February 16, 2007
APPL NO 11/707421
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/326
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872396 Chiang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Yet-Ming Chiang (Framingham, Massachusetts);  Michael J. Cima (Medford, Massachusetts);  Timothy E. Chin (Cambridge, Massachusetts)
ABSTRACT The present invention provides systems, devices, and related methods, involving electrochemical actuation. In some cases, application of a voltage or current to a system or device of the invention may generate a volumetric or dimensional change, which may produce mechanical work. For example, at least a portion of the system may be constructed and arranged to be displaced from a first orientation to a second orientation. Systems such as these may be useful in various applications, including pumps (e.g., infusion pumps) and drug delivery devices, for example.
FILED Thursday, July 26, 2007
APPL NO 11/881830
ART UNIT 2837 — Electrical Circuits and Systems
CURRENT CPC
Electrical generator or motor structure
310/311
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872468 Mitrofanov
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S)
ASSIGNEE(S) Alcatel-Lucent USA Inc. (Murray Hill, New Jersey)
INVENTOR(S) Oleg Mitrofanov (New York, New York)
ABSTRACT An apparatus includes an optical resonator and a passive optical device. The optical resonator has first and second optical reflectors and an optical cavity interposed between the reflectors. The optical resonator includes an electro-optically responsive material. One of the reflectors is a distributed Bragg reflector. A passive optical device is configured to direct light through the first optical reflector. The optical resonator is configured to return a portion of the light through the first reflector.
FILED Monday, January 28, 2008
APPL NO 12/011602
ART UNIT 2829 — Semiconductors/Memory
CURRENT CPC
Electricity: Measuring and testing
324/96
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872563 Braun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Paul V. Braun (Savoy, Illinois);  Xindi Yu (Urbana, Illinois)
ABSTRACT A method of making a monolithic porous structure, comprises electrodepositing a material on a template; removing the template from the material to form a monolithic porous structure comprising the material; and electropolishing the monolithic porous structure.
FILED Monday, April 09, 2007
APPL NO 11/733151
ART UNIT 2833 — Electrical Circuits and Systems
CURRENT CPC
Electrical resistors
338/20
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872758 Ward et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S)
ASSIGNEE(S) The Charles Stark Draper Laboratory, Inc. (Cambridge, Massachusetts)
INVENTOR(S) Paul A. Ward (Dedham, Massachusetts);  Michael Kishinevsky (North Andover, Massachusetts);  Matthew Soucy (Hopkinton, Massachusetts);  Stephen P. Smith (Acton, Massachusetts);  Farhad Zarinetchi (Chelmsford, Massachusetts)
ABSTRACT Determining linear modulator dynamics in an interferometric fiber-optic gyroscope may be accomplished by applying a stimulus at a point within the gyroscope, observing a response in an output of the gyroscope, and determining, from the observed response, the linear modulator dynamics.
FILED Tuesday, January 22, 2008
APPL NO 12/018016
ART UNIT 2886 — Optics
CURRENT CPC
Optics: Measuring and testing
356/460
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872794 Minelly et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S)
ASSIGNEE(S) Lockheed Martin Corporation (Bethesda, Maryland)
INVENTOR(S) John D. Minelly (Bothell, Washington);  Deborah A. Alterman (Seattle, Washington)
ABSTRACT An apparatus and that provide an optical-fiber amplifier having at least one erbium-doped fiber section and an optical pump coupled to the erbium-doped fiber section, wherein the apparatus is operable to amplify signal pulses to high energy in the erbium-doped fiber section, the pulses having a wavelength in the range of about 1565 nm to about 1630 nm. In some embodiments, the amplifying fiber is ytterbium free.
FILED Tuesday, January 22, 2008
APPL NO 12/018193
ART UNIT 3663 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Optical: Systems and elements
359/341.310
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872850 Pelrine et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S)
ASSIGNEE(S) SRI International (Menlo Park, California)
INVENTOR(S) Ronald E. Pelrine (Longmont, Colorado);  Harsha Prahlad (Cupertino, California);  Roy D. Kornbluh (Palo Alto, California);  Patrick D. Lincoln (Woodside, California);  Scott Stanford (Mountain View, California)
ABSTRACT Described herein is electroadhesion technology that permits controllable adherence between two objects. Electroadhesion uses electrostatic forces of attraction produced by an electrostatic adhesion voltage, which is applied using electrodes in an electroadhesive device. The electrostatic adhesion voltage produces an electric field and electrostatic adherence forces. When the electroadhesive device and electrodes are positioned near a surface of an object such as a vertical wall, the electrostatic adherence forces hold the electroadhesive device in position relative to the surface and object. This can be used to increase traction or maintain the position of the electroadhesive device relative to a surface. Electric control of the electrostatic adhesion voltage permits the adhesion to be controllably and readily turned on and off.
FILED Friday, May 15, 2009
APPL NO 12/467080
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Electricity: Electrical systems and devices
361/234
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873280 Haney et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S)
ASSIGNEE(S) University of Delaware (Newark, Delaware)
INVENTOR(S) Michael W. Haney (Oak Hill, Virginia);  Michael J. McFadden (McLean, Virginia);  Muzammil Iqbal (San Diego, California)
ABSTRACT A method and apparatus for achieving high-density and misalignment tolerant short-reach free-space optical interconnects between arbitrary locations in a field, using microlenses, steering elements and a curved reflecting surface.
FILED Friday, December 15, 2006
APPL NO 11/611414
ART UNIT 2613 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
CURRENT CPC
Optical communications
398/118
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873686 Elfataoui et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
APPLICANT(S)
ASSIGNEE(S) The University of Vermont and State Agricultural College (Burlington, Vermont)
INVENTOR(S) Mohamed Elfataoui (Burlington, Vermont);  Gagan Mirchandani (Burlington, Vermont)
ABSTRACT An electrical signal filter for processing a discrete-time real signal having a length N. In one embodiment, the filter comprising a delay line having N taps and a corresponding respective N filter coefficients. Values for the filter coefficients are determined by first shifting an impulse function of length N by a fraction of N so as to obtain a shifted impulse function. An analytic-signal-generating method is then applied to the impulse function so as to output the filter coefficient values. The values are then assigned to the N taps to complete the filter.
FILED Wednesday, August 02, 2006
APPL NO 11/498607
ART UNIT 2193 — Interprocess Communication and Software Development
CURRENT CPC
Electrical computers: Arithmetic processing and calculating
78/319
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873879 Arimilli et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Lakshminarayana B. Arimilli (Austin, Texas);  Robert S. Blackmore (Poughkeepsie, New York);  Chulho Kim (Poughkeepsie, New York);  Ramakrishnan Rajamony (Austin, Texas);  Hanhong Xue (Poughkeepsie, New York)
ABSTRACT A host fabric interface (HFI) enables debugging of global shared memory (GSM) operations received at a local node from a network fabric. The local node has a memory management unit (MMU), which provides an effective address to real address (EA-to-RA) translation table that is utilized by the HFI to evaluate when EAs of GSM operations/data from a received GSM packet is memory-mapped to RAs of the local memory. The HFI retrieves the EA associated with a GSM operation/data within a received GSM packet. The HFI forwards the EA to the MMU, which determines when the EA is mapped to RAs within the local memory for the local task. The HFI processing logic enables processing of the GSM packet only when the EA of the GSM operation/data within the GSM packet is an EA that has a local RA translation. Non-matching EAs result in an error condition that requires debugging.
FILED Friday, February 01, 2008
APPL NO 12/024585
ART UNIT 2114 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Error detection/correction and fault detection/recovery
714/53
VIEW PATENT @ USPTO:  Full Text   PDF 
US D630868 Annicelli
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Lance L. Annicelli (Schertz, Texas)
ABSTRACT
FILED Thursday, October 01, 2009
APPL NO 29/316481
ART UNIT 2913 — Design
CURRENT CPC
Furnishings
D6/457
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Health and Human Services (HHS) 

US 07871366 Criscione et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S)
ASSIGNEE(S) The Texas A and M University System (College Station, Texas);  Corinnova Incorporated (Houston, Texas)
INVENTOR(S) John C. Criscione (College Station, Texas);  Saurabh Biswas (Bryan, Texas);  Stan Hall (Colleyville, Texas);  Lewis Harrison (Arlington, Texas);  Dennis Robbins (Richardson, Texas)
ABSTRACT The present invention provides methods, systems, kits and devices that reduce dyskinesis and hypokinesis. For example, the direct compression cardiac device may be positioned about at least a portion of a heart, and includes a resilient inner panel in contact with at least a portion of the heart periphery, one or more resilient members positioned about the resilient inner panel and at least partially surrounded by an expandable outer panel. The resistance supplied by the inner panel to the heart may be modulated to control the end-diastolic heart volume and remodel the heart, the resistance supplied by the expandable outer panel to the heart may be modulated to control the end-systolic heart volume and remodel the heart or both.
FILED Monday, July 30, 2007
APPL NO 11/830488
ART UNIT 3766 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Surgery
6/16
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871456 Gough et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) David A. Gough (Solana Beach, California);  Joseph Y. Lucisano (San Diego, California);  Joe T. Lin (San Diego, California);  Hwai-Min Tsay (San Diego, California);  Drahoslav Lim (San Diego, California);  Jana Limova, legal representative (San Diego, California)
ABSTRACT A membrane for use in an implantable glucose sensor including at least one crosslinked substantially hydrophobic polymer and at least one crosslinked substantially hydrophilic polymer; wherein the first and second polymers are different polymers and substantially form an interpenetrating polymer network, semi-interpenetrating polymer network, polymer blend, or copolymer. The membranes are generally characterized by providing a permeability ratio of oxygen to glucose of about 1 to about 1000 in units of (mg/dl glucose) per (mmHg oxygen). Three methods of making membranes from hydrophobic and hydrophilic monomers formed into polymer networks are provided, wherein according to at least two of the methods, the monomers may be substantially immiscible with one another.
FILED Thursday, August 10, 2006
APPL NO 11/503461
ART UNIT 1775 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas separation: Processes
095/45
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871604 Curtiss, III et al.
FUNDED BY
Department of Health and Human Services (HHS)
U.S. Public Health Service (USPHS)
APPLICANT(S)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Roy Curtiss, III (St. Louis, Missouri);  Steven A. Tinge (Belleville, Illinois)
ABSTRACT Disclosed is an Environmentally Limited Viability System (ELVS) for microorganisms based on temperature differences between permissive and non-permissive environments. Viability of the microorganisms are limited to the permissive environment by specifically expressing one or more essential genes only in the permissive environment, or expressing one or more lethal genes only in the non-permissive environment. Environmentally Limited Viability Systems are also disclosed involving coordinate expression of a combination of required genes and lethal genes. Microorganisms containing an Environmentally Limited Viability System are useful for release into a permissive environment. Temperature regulated Environmentally Limited Viability Systems are particularly suited for use with recombinant avirulent Salmonella vaccines by limiting their growth to the warmer environment inside the host. Such vaccines can be administered to protect humans or warm-blooded animals against bacterial, viral, mycotic and parasitic pathogens, especially those that colonize on or invade through mucosal surfaces. This antigen delivery system can also be used for expression of gamete-specific antigens to induce immune responses to block fertilization, or to induce immune responses to tumor antigens. In the event that an individual sheds live vaccine into the environment, the presence of the ELVS prevents survival of the vaccine. When environmentally regulated lethal genes are present on an extrachromosomal element and are regulated by chromosomal genes, transfer of the extrachromosomal element to other microorganisms will be limited by unregulated expression of the lethal genes in the recipient microorganism.
FILED Wednesday, July 22, 1998
APPL NO 09/120970
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/93.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871612 Abrahamson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Julie A. Abrahamson (Harlow, United Kingdom);  Connie L Erickson-Miller (King of Prussia, Pennsylvania);  Kristine K. Kikly (Fortville, Indiana);  Bruce Bochner (Lutherville, Maryland);  Robert Schleimer (Baltimore, Maryland);  T. Esra Nutku (Baltimore, Maryland)
ABSTRACT Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.
FILED Thursday, October 12, 2006
APPL NO 11/546586
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/130.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871620 Benz et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Christopher C. Benz (Novato, California);  Demetrios P. Papahadjopoulos (San Francisco, California);  Francis C. Szoka, legal representative (San Francisco, California);  John W. Park (San Francisco, California);  Keelung Hong (San Francisco, California);  Dmitri Kirpotin (San Francisco, California)
ABSTRACT The present invention provides for immunoliposomes that optimizes internalization of a drug into target cells bearing a characteristic cell surface marker. The immunoliposomes comprise an Fab′ domain of an antibody that specifically binds the characteristic marker, an amphipathic vesicle-forming lipid, and a polyethylene glycol derivatized lipid. The invention also provides for growth-inhibiting immunoliposomes that lack growth-inhibiting therapeutic agents and yet are capable of inhibiting the growth and proliferation of target cells.
FILED Thursday, February 12, 2009
APPL NO 12/370038
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/143.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871623 Biswal et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Sandip Biswal (Stanford, California);  Francis G. Blankenberg (Portola Valley, California)
ABSTRACT Briefly described, embodiments of the present disclosure relate to methods and compositions for imaging pain and/or stress in a subject and methods and compositions for treating associated conditions. In particular, the present disclosure relates to the use of labeled compounds to provide objective diagnosis of pain and/or stress, for imaging regions associated with pain and/or stress, and for treating pain in a subject.
FILED Thursday, December 21, 2006
APPL NO 11/643249
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/185.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871626 Hoffmann et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S)
ASSIGNEE(S) St. Jude Children's Research Hospital (Memphis, Tennessee)
INVENTOR(S) Erich Hoffmann (Memphis, Tennessee);  Aleksandr S. Lipatov (Bartlett, Tennessee);  Richard J. Webby (Memphis, Tennessee);  Elena A. Govorkova (Cordova, Tennessee);  Robert G. Webster (Memphis, Tennessee)
ABSTRACT The immunogenicity of the influenza virus hemagglutinin (HA) molecule may be increased by substitutions of amino acids in the HA sequence. The substitution of specific HA residues, such as asparagine at position 223 of H5 HA, increase the sensitivity of the hemagglutinin inhibition (HI) assay by altering receptor specificity and/or antibody-antigen binding. HA molecules containing such substitutions will be useful in the development of diagnostic reference viruses and improved influenza vaccines.
FILED Thursday, July 27, 2006
APPL NO 11/460584
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/206.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871776 Supattapone et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S)
ASSIGNEE(S) Trustees of Dartmouth College (Hanover, New Hampshire)
INVENTOR(S) Surachai Supattapone (Hanover, New Hampshire);  Nathan Deleault (Canaan, New Hampshire)
ABSTRACT A method for purifying PrPc, a purified preparation of PrPc and methods and kits for identifying the presence of PrPc are provided.
FILED Monday, January 08, 2007
APPL NO 12/090101
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871777 Schneider et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Thomas D. Schneider (Frederick, Maryland);  Ilya G. Lyakhov (Frederick, Maryland);  Danielle Needle (Frederick, Maryland)
ABSTRACT A nanoprobe for sequencing of nucleic acid molecules is provided, as well as methods for using the nanoprobe. In particular examples, the probe includes a polymerizing agent and one or more molecular linkers that carry a chemical moiety capable of reversibly binding to the template strand of a nucleic acid molecule, without being detached from the linker, by specifically binding with a complementary nucleotide in the target nucleic acid molecule. The reversible binding of the chemical moiety on the linker with a complementary nucleotide in the target nucleic acid molecule is indicated by emission of a characteristic signal that indicates pairing of the chemical moiety on the linker with its complementary nucleotide. An example of such a chemical moiety is a nonhydrolyzable nucleotide analog. In particular examples, the polymerizing agent and the chemical moiety are associated with a tag, such as a donor fluorophore and acceptor fluorophore characteristic of the particular type of chemical moiety.
FILED Tuesday, December 12, 2006
APPL NO 12/095973
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871778 Giudice
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Child Health and Human Development (NICHD)
APPLICANT(S)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Linda C. Giudice (Los Altos Hills, California)
ABSTRACT The present invention provides biomarkers for the diagnosis and prognosis of endometriosis. Generally, the methods of this invention find use in diagnosing or for providing a prognosis for endometriosis by detecting the expression levels of biomarkers, which are differentially expressed (up- or down-regulated) in endometrial cells from a patient with endometriosis. Similarly, these markers can be used to diagnose reduced fertility in a patient with endometriosis or to provide a prognosis for a fertility trial in a patient suffering from endometriosis. The present invention also provides methods of identifying a compound for treating or preventing endometriosis. Finally, the present invention provides kits for the diagnosis or prognosis of endometriosis.
FILED Thursday, April 24, 2008
APPL NO 12/109099
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871779 Morrison et al.
FUNDED BY
Department of Health and Human Services (HHS)
Centers for Disease Control and Prevention (CDC)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention (Washington, District of Columbia)
INVENTOR(S) Christine J. Morrison (Decatur, Georgia);  Hans Peter Hinrikson (Wallisellen, Switzerland)
ABSTRACT Novel techniques for the detection of Aspergillus in samples are disclosed. These techniques relate to PCR amplification and/or detection of Aspergillus ITS1 rDNA sequences, and the identification of particular species of Aspergillus by detecting differences in the ITS1-V1, ITS-V2, ITS-V3, ITS-V4, and ITS-V5 nucleic acid sequences of Aspergillus. The highly variable regions of the ITS1 rDNA sequences are particularly useful in distinguishing, for example, Aspergillus clavatus, Aspergillus granulosus, Aspergillus sydowii, Aspergillus flavipes, Aspergillus restrictus, Aspergillus versicolor, Aspergillus wentii, and Aspergillus chevalieri. In particular embodiments, the sequence differences are also able to distinguish among variants of particular species, such as Aspergillus granulosus CBS 119.5A, Aspergillus granulosus strain NRRL 1932, Aspergillus sydowii strain NRRL 250, Aspergillus sydowii strain NRRL 4768, Aspergillus sydowii strain CUHI, Aspergillus sydowii strain CUH2, Aspergillus sydowii strain CUH7, and Aspergillus sydowii strain CUH8.
FILED Monday, May 05, 2008
APPL NO 12/115493
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871784 Kufe
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Donald W. Kufe (Wellesley, Massachusetts)
ABSTRACT This invention relates to regulation of cell signaling, cell growth, and more particularly to the regulation of cancer or immune cell growth. The invention provides methods of inhibiting interactions between MUC1 and BH3-containing proapoptotic proteins, methods of inhibiting MUC1 expression, and methods of promoting apoptosis. Also provided are screening methods for compounds that inhibit interactions between MUC1 and BH3-containing proapoptotic proteins and pharmaceutical compositions of the same.
FILED Friday, February 01, 2008
APPL NO 12/024715
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/7.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871787 Fazleabas
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Asgerally T. Fazleabas (Chicago, Illinois)
ABSTRACT Provided herein is a method for diagnosing and monitoring endometriosis in a subject by measuring levels of the β-subunit of fibrinogen.
FILED Friday, June 25, 2010
APPL NO 12/823247
ART UNIT 1641 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/7.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871790 Frucht et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) David M. Frucht (Vienna, Virginia);  Ruth Cordoba-Rodriguez (Baltimore, Maryland)
ABSTRACT Based on the observation that exposure of cells or animals to anthrax lethal toxin results in activation of the intracellular enzyme caspase-1/IL-1 converting enzyme (ICE), which, in turn, leads to production and extracellular release of the cytokine substrates of ICE: interleukin 1 beta (IL-1β) and interleukin 18 (IL-18), disclosed herein are bioassays that can be used to determine the efficacy of a potential anthrax therapeutic agent and for screening test agents to identify anthrax therapeutic agents. Also disclosed herein are methods of diagnosing and treating anthrax infection.
FILED Wednesday, March 02, 2005
APPL NO 11/071799
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/32
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871793 Nakayama et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S)
ASSIGNEE(S) Burnham Institute for Medical Research (La Jolla, California)
INVENTOR(S) Jun Nakayama (Matsumoto, Japan);  Masatomo Kawakubo (Higashichikuma-Gun, Japan);  Minoru Fukuda (San Diego, California);  Tsutomu Katsuyama (Matsumoto, Japan)
ABSTRACT Compositions useful for inhibiting the growth of bacteria, including bacteria that can cause gastric ulcers, are provided. In addition, transgenic organism that can produce such compositions are provided. Methods of using the compositions to treat or prevent gastric ulcers in a subject, including a human subject, also are provided.
FILED Friday, February 18, 2005
APPL NO 10/589841
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/68.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871814 Andino-Pavlovsky et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Raul Andino-Pavlovsky (San Francisco, California);  Andres McAllister-Moreno (Geneva, Switzerland)
ABSTRACT The present invention provides recombinant bicistronic flaviviruses, particularly live attenuated recombinant bicistronic flavivirus, which comprise, in order from 5′ to 3′, a viral 5′UTR, an ORF encoding all viral proteins, an internal ribosome entry site, an exogenous nucleotide sequence that encodes an exogenous polypeptide, and a viral 3′UTR. Infection of a host cell with a recombinant flavivirus provides for expression of the exogenous nucleic acid in a host cell. Such recombinant flavivirus are useful for delivering a protein to a mammalian host; and for eliciting an immune response to the exogenous polypeptide.
FILED Thursday, May 09, 2002
APPL NO 10/477504
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/320.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871981 Bottaro et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Donald P Bottaro (Kensington, Maryland);  Alessio Giubellino (Bethesda, Maryland);  Safiye N Atabey (Alsancak, Turkey);  Jesus V Soriano (Washington, District of Columbia);  Diane E Breckenridge (Bethesda, Maryland);  Terrence R Burke, Jr. (Bethesda, Maryland)
ABSTRACT Disclosed are methods of inhibiting cell motility, for example, by inhibiting the binding between an intracellular transducer and a receptor protein tyrosine kinase, and more particularly by inhibiting hepatocyte growth factor (HGF) induced cell motility. The present invention also provides a method of inhibiting angiogenesis. The methods of the present invention employ peptides such as phosphotyrosyl mimetics. Also disclosed are methods of preventing and/or treating diseases, disorders, states, or conditions such as cancer, particularly metastatic cancer, for example, melanoma or prostate cancer, comprising administering to a mammal of interest one or more peptides of the present invention. Also disclosed are methods of blocking blocks HGF, VEGF, or bFGF-stimulated migration, cell proliferation, and formation of capillary-like structures.
FILED Friday, September 22, 2006
APPL NO 11/525672
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/19.800
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871985 de Fougerolles et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) Alnylam Pharmaceuticals, Inc. (Cambridge, Massachusetts)
INVENTOR(S) Antonin de Fougerolles (Cambridge, Massachusetts);  Tatiana Novobrantseva (Cambridge, Massachusetts);  Akin Akinc (Cambridge, Massachusetts)
ABSTRACT The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the Factor VII gene.
FILED Wednesday, December 10, 2008
APPL NO 12/331708
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/44
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871986 Schlom et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Jeffrey Schlom (Potomac, Maryland);  Kwong-Yok Tsang (Bethesda, Maryland);  Sam Zaremba (Rockville, Maryland)
ABSTRACT The invention provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines. In particular, the invention provides methods for eliciting an immune response against PSA comprising administering (i) a priming inoculation of a first recombinant virus encoding PSA-OP and (ii) one or more boosting inoculations of a second recombinant virus encoding PSA-OP, wherein the first and second recombinant viruses are from a different genus.
FILED Friday, June 05, 2009
APPL NO 12/479292
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/44.R00
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871996 Weinberg et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Joe Brice Weinberg (Durham, North Carolina);  Dipak Kumar Ghosh (Durham, North Carolina)
ABSTRACT The present invention provides methods of inhibiting nitric oxide synthase (NOS) using corrin derivatives that bind NOS but do not bind NO. It also provides methods of inhibiting NOS in vivo by administering corrin derivatives, and methods of treating diseases and medical conditions using this inhibition of NOS.
FILED Friday, September 28, 2007
APPL NO 11/904747
ART UNIT 1614 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/186
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872016 Eswarakumar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Veraragavan Palani Eswarakumar (New Haven, Connecticut);  Joseph P. Schlessinger (Woodbridge, Connecticut);  Irit Lax (Woodbridge, Connecticut)
ABSTRACT The invention provides materials, reagents, systems, and methods for identifying agents useful for treating diseases resulting from abnormal (e.g., excessive) FGF receptor signaling. The invention also provides (therapeutic) agents thus identified, and methods of using such agents in treating such diseases. In certain embodiments, the invention relates to the treatment of various craniofacial disorders, or Craniosynostosis, that result from FGFR (e.g. FGFR2) malfunction, such as Crouzon, Apert, Jackson-Weiss, Pfeiffer Syndromes, Crouzon+acanthosis nigricans, Beare-Stevenson cutis gyrata, and non-syndromic craniosynostosis (NS). The methods comprise administering to the individuals a therapeutically effective amount of an inhibitor of the FGFR2c-FRS2 signaling. The inhibitor inhibits signaling by antagonizing FGFR2c-FRS2 interaction, inhibiting the expression and/or subcellular localization of wild-type or mutant FGFR2c and/or FRS2, inhibiting the kinase activity of FGFR2c (e.g. for autophosphorylation and/or phosphorylation of FRS2), and/or inhibiting downstream signaling of FRS2 (such as Sos-Ras-MAPK, Shp2, and/or Gab 1-PI3K pathways).
FILED Wednesday, May 25, 2005
APPL NO 11/597487
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/300
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872037 Hruby et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S)
ASSIGNEE(S) Siga Technologies, Inc. (Corvallis, Oregon)
INVENTOR(S) Dennis E. Hruby (Albany, Oregon);  Tové C. Bolken (Keizer, Oregon);  Sean Amberg (Corvallis, Oregon);  Dongcheng Dai (Corvallis, Oregon)
ABSTRACT Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pichinde, and LCMV), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever).
FILED Friday, March 02, 2007
APPL NO 11/712918
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/394
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872048 Simard
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S)
ASSIGNEE(S) University of Maryland, Baltimore (Baltimore, Maryland)
INVENTOR(S) J. Marc Simard (Baltimore, Maryland)
ABSTRACT The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NCCa-ATP channel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
FILED Friday, September 16, 2005
APPL NO 11/229236
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/592
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872094 May et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Michael J. May (New Haven, Connecticut);  Sankar Ghosh (Madison, Connecticut)
ABSTRACT The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-κB-dependent target gene expression in a cell.
FILED Wednesday, April 15, 2009
APPL NO 12/424334
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
530/300
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872123 Momiyama et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S)
ASSIGNEE(S) Japan Science And Technology Agency (Saitama, Japan)
INVENTOR(S) Norie Momiyama (Sendai, Japan);  Hiromi Torii (Kariya, Japan);  Susumu Saito (Nagoya, Japan);  Hisashi Yamamoto (Chicago, Illinois);  Yuhei Yamamoto (Tsukuba, Japan)
ABSTRACT The present invention is directed to a process of making α-aminooxyketone and α-hydroxyketone compounds. The synthetic pathway involves reacting an aldehyde or ketone substrate and a nitroso substrate in the presence of a catalyst of the formula (IV):
wherein Xa-Xc represent independently nitrogen, carbon, oxygen or sulfur and Z represents a 4 to 10-membered ring with or without a substituent and optionally a further step to convert the α-aminooxyketone compound formed to the α-hydroxyketone compound which results in α-aminooxyketone and α-hydroxyketone compounds with high enantioselectivity and high purity. The present invention is also directed to a catalytic asymmetric O-nitroso Aldol/Michael reaction involving a cyclic α,β-unsaturated ketone substrate and a nitroso substrate. This methodology involves reacting the cyclic α,β-unsaturated ketone substrate and the nitroso substrate in the presence of a proline-based catalyst, to provide a heterocyclic product.
FILED Friday, August 18, 2006
APPL NO 11/506590
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Organic compounds
544/63
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872152 Serhan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
INVENTOR(S) Charles N. Serhan (Needham, Massachusetts);  Bruce D. Levy (West Roxbury, Massachusetts)
ABSTRACT The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), cyclooxygenase-II (COX-2) and an analgesic, such as aspirin (ASA). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy EPA or DHA compounds having unique structural and physiological properties. The present invention therefore provides for many new useful therapeutic di- or tri-hydroxy derivatives of EPA or DHA (resolvins) that diminish, prevent, or eliminate inflammation or PMN migration, for example. The present invention also provides methods of use, methods of preparation, and packaged pharmaceuticals for use as medicaments for the compounds disclosed throughout the specification.
FILED Thursday, August 09, 2007
APPL NO 11/836460
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Organic compounds
560/205
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873419 Greenberg et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S)
ASSIGNEE(S) Second Sight Medical Products, Inc. (Sylmar, California)
INVENTOR(S) Robert J. Greenberg (Los Angeles, California);  Jerry Ok (Canyon Country, California);  Jordan Neysmith (Pasadena, California);  Kevin Wilkin (Valencia, California);  Neil Hamilton Talbot (La Crescenta, California);  Da-Yu Chang (Rowland Heights, California)
ABSTRACT An improved package and configuration for an implantable retinal prosthesis includes an electrode array suitable to be mounted in close proximity to a retina, an electronics package, and an inductive receiving coil mounted next to each other on a strap surrounding the sclera so that the height above the sclera of the prosthesis is minimized.
FILED Monday, October 29, 2007
APPL NO 11/927315
ART UNIT 3766 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
CURRENT CPC
Surgery: Light, thermal, and electrical application
67/54
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873480 Rimm et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) David L. Rimm (Branford, Connecticut);  Robert L Camp (Stamford, Connecticut)
ABSTRACT Systems and methods for rapidly analyzing cell containing samples, for example to identify morphology or to localize and quantitate biomarkers are disclosed.
FILED Monday, August 20, 2007
APPL NO 11/894680
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Data processing: Measuring, calibrating, or testing
72/19
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 07870905 Hermes et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
APPLICANT(S)
ASSIGNEE(S) Chevron U.S.A. Inc. (San Ramon, California);  Los Alamos National Security, LLC (Los Alamos, New Mexico)
INVENTOR(S) Robert E. Hermes (Los Alamos, New Mexico);  Manuel E. Gonzalez (Kingwood, Texas);  Brian C. Llewellyn (Kingwood, Texas);  James B. Bloys (Katy, Texas)
ABSTRACT A process is described for replacing at least a portion of the liquid within the annular volume of a casing system within a wellbore with a second liquid. The second liquid is preselected to provide a measure of control of the pressure within the annular volume as the fluid within the volume is being heated.
FILED Friday, March 12, 2010
APPL NO 12/723528
ART UNIT 3676 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Wells
166/302
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871198 Rempe et al.
FUNDED BY
Department of Energy (DOE)
Office of Nuclear Energy (DOE-NE)
Idaho National Laboratory (INL)
Federally Funded Research and Development Center (FFRDC)
Operated by Battelle Energy Alliance, LLC (BEA) at Idaho Falls, ID
APPLICANT(S)
ASSIGNEE(S) Battelle Energy Alliance, LLC (Idaho Falls, Idaho)
INVENTOR(S) Joy L. Rempe (Idaho Falls, Idaho);  Darrell L. Knudson (Firth, Idaho);  Keith G. Condie (Idaho Falls, Idaho);  S. Curt Wilkins (Idaho Falls, Idaho)
ABSTRACT A high-temperature thermocouple and methods for fabricating a thermocouple capable of long-term operation in high-temperature, hostile environments without significant signal degradation or shortened thermocouple lifetime due to heat induced brittleness.
FILED Monday, February 26, 2007
APPL NO 11/678901
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Thermal measuring and testing
374/179
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871246 Liang
FUNDED BY
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) Siemens Energy, Inc. (Orlando, Florida)
INVENTOR(S) George Liang (Palm City, Florida)
ABSTRACT An airfoil is provided for a gas turbine comprising an outer structure comprising a first wall, an inner structure comprising a second wall spaced relative to the first wall such that a cooling gap is defined between at least portions of the first and second walls, and seal structure provided within the cooling gap between the first and second walls for separating the cooling gap into first and second cooling fluid impingement gaps. An inner surface of the second wall may define an inner cavity. The inner structure may further comprise a separating member for separating the inner cavity of the inner structure into a cooling fluid supply cavity and a cooling fluid collector cavity. The second wall may comprise at least one first impingement passage, at least one second impingement passage, and at least one bleed passage.
FILED Thursday, February 15, 2007
APPL NO 11/707192
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Fluid reaction surfaces
416/97.R00
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871661 Maghribi et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Mariam N. Maghribi (Livermore, California);  Peter A. Krulevitch (Pleasanton, California);  Thomas S. Wilson (Castro Valley, California);  Julie K. Hamilton (Tracy, California);  Christina Park (Cambridge, Massachusetts)
ABSTRACT A stretchable electronic apparatus and method of producing the apparatus. The apparatus has a central longitudinal axis and the apparatus is stretchable in a longitudinal direction generally aligned with the central longitudinal axis. The apparatus comprises a stretchable polymer body, and at least one circuit line operatively connected to the stretchable polymer body, the at least one circuit line extending in the longitudinal direction and having a longitudinal component that extends in the longitudinal direction and having an offset component that is at an angle to the longitudinal direction, the longitudinal component and the offset component allowing the apparatus to stretch in the longitudinal direction while maintaining the integrity of the at least one circuit line.
FILED Wednesday, July 11, 2007
APPL NO 11/827612
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Coating processes
427/58
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871738 Stamenkovic et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S)
ASSIGNEE(S) UChicago Argonne, LLC (Chicago, Illinois)
INVENTOR(S) Vojislav Stamenkovic (Naperville, Illinois);  Nenad M. Markovic (Hinsdale, Illinois)
ABSTRACT A method of preparing a nanosegregated Pt alloy having enhanced catalytic properties. The method includes providing a sample of Pt and one or more of a transition metal in a substantially inert environment, and annealing the sample in such an environment for a period of time and at a temperature profile to form a nanosegregated Pt alloy having a Pt-skin on a surface. The resulting alloy is characterized by a plurality of compositionally oscillatory atomic layers resulting in an advantageous electronic structure with enhanced catalytic properties.
FILED Thursday, December 18, 2008
APPL NO 12/338736
ART UNIT 1793 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemistry: Electrical current producing apparatus, product, and process
429/524
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871764 Bavykin
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the United States Department of Energy (Washington, District of Columbia)
INVENTOR(S) Sergei Bavykin (Darien, Illinois)
ABSTRACT The present invention relates to a method for extracting nucleic acids from biological samples. More specifically the invention relates to a universal method for extracting nucleic acids from unidentified biological samples. An advantage of the presently invented method is its ability to effectively and efficiently extract nucleic acids from a variety of different cell types including but not limited to prokaryotic or eukaryotic cells and/or recalcitrant organisms (i.e. spores). Unlike prior art methods which are focused on extracting nucleic acids from vegetative cell or spores, the present invention effectively extracts nucleic acids from spores, multiple cell types or mixtures thereof using a single method. Important that the invented method has demonstrated an ability to extract nucleic acids from spores and vegetative bacterial cells with similar levels effectiveness. The invented method employs a multi-step protocol which erodes the cell structure of the biological sample, isolates, labels, fragments nucleic acids and purifies labeled samples from the excess of dye.
FILED Tuesday, March 18, 2008
APPL NO 12/050508
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/4
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871799 Gardner et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Shea N. Gardner (San Leandro, California);  Raymond P. Mariella, Jr. (Danville, California);  Allen T. Christian (Tracy, California);  Jennifer A. Young (Berkeley, California);  David S. Clague (Livermore, California)
ABSTRACT A method of fabricating a DNA molecule of user-defined sequence. The method comprises the steps of preselecting a multiplicity of DNA sequence segments that will comprise the DNA molecule of user-defined sequence, separating the DNA sequence segments temporally, and combining the multiplicity of DNA sequence segments with at least one polymerase enzyme wherein the multiplicity of DNA sequence segments join to produce the DNA molecule of user-defined sequence. Sequence segments may be of length n, where n is an even or odd integer. In one embodiment the length of desired hybridizing overlap is specified by the user and the sequences and the protocol for combining them are guided by computational (bioinformatics) predictions. In one embodiment sequence segments are combined from multiple reading frames to span the same region of a sequence, so that multiple desired hybridizations may occur with different overlap lengths. In one embodiment starting sequence fragments are of different lengths, n, n+1, n+2, etc.
FILED Wednesday, December 03, 2003
APPL NO 10/727779
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/91.200
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871824 Morozov
FUNDED BY
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) George Mason Intellectual Properties, Inc. (Fairfax, Virginia)
INVENTOR(S) Victor Morozov (Manassas, Virginia)
ABSTRACT A flow chamber having a vacuum chamber and a specimen chamber. The specimen chamber may have an opening through which a fluid may be introduced and an opening through which the fluid may exit. The vacuum chamber may have an opening through which contents of the vacuum chamber may be evacuated. A portion of the flow chamber may be flexible, and a vacuum may be used to hold the components of the flow chamber together.
FILED Wednesday, April 05, 2006
APPL NO 11/397911
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemistry: Analytical and immunological testing
436/52
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871957 Willigan et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) UTC Power Corporation (South Windsor, Connecticut)
INVENTOR(S) Rhonda R. Willigan (Manchester, Connecticut);  Thomas Henry Vanderspurt (Glastonbury, Connecticut);  Sonia Tulyani (Manchester, Connecticut);  Rakesh Radhakrishnan (Vernon, Connecticut);  Susanne Marie Opalka (Glastonbury, Connecticut);  Sean C. Emerson (Broad Brook, Connecticut)
ABSTRACT A durable catalyst support/catalyst is capable of extended water gas shift operation under conditions of high temperature, pressure, and sulfur levels. The support is a homogeneous, nanocrystalline, mixed metal oxide of at least three metals, the first being cerium, the second being Zr, and/or Hf, and the third importantly being Ti, the three metals comprising at least 80% of the metal constituents of the mixed metal oxide and the Ti being present in a range of 5% to 45% by metals-only atomic percent of the mixed metal oxide. The mixed metal oxide has an average crystallite size less than 6 nm and forms a skeletal structure with pores whose diameters are in the range of 4-9 nm and normally greater than the average crystallite size. The surface area of the skeletal structure per volume of the material of the structure is greater than about 240 m2/cm3. The method of making and use are also described.
FILED Tuesday, May 15, 2007
APPL NO 11/803481
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Catalyst, solid sorbent, or support therefor: Product or process of making
52/304
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872054 Cortright et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin);  Virent Energy Systems (Madison, Wisconsin)
INVENTOR(S) Randy D. Cortright (Madison, Wisconsin);  James A. Dumesic (Verona, Wisconsin)
ABSTRACT A low-temperature catalytic process for converting biomass (preferably glycerol recovered from the fabrication of bio-diesel) to synthesis gas (i.e., H2/CO gas mixture) in an endothermic gasification reaction is described. The synthesis gas is used in exothermic carbon-carbon bond-forming reactions, such as Fischer-Tropsch, methanol, or dimethylether syntheses. The heat from the exothermic carbon-carbon bond-forming reaction is integrated with the endothermic gasification reaction, thus providing an energy-efficient route for producing fuels and chemicals from renewable biomass resources.
FILED Friday, March 23, 2007
APPL NO 11/690533
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Chemistry: Fischer-Tropsch processes; or purification or recovery of products thereof
518/700
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872563 Braun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Paul V. Braun (Savoy, Illinois);  Xindi Yu (Urbana, Illinois)
ABSTRACT A method of making a monolithic porous structure, comprises electrodepositing a material on a template; removing the template from the material to form a monolithic porous structure comprising the material; and electropolishing the monolithic porous structure.
FILED Monday, April 09, 2007
APPL NO 11/733151
ART UNIT 2833 — Electrical Circuits and Systems
CURRENT CPC
Electrical resistors
338/20
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873811 Wolinski et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the United States Department of Energy (Washington, District of Columbia)
INVENTOR(S) Christophe Czeslaw Wolinski (Los Alamos, New Mexico);  Maya B. Gokhale (Los Alamos, New Mexico);  Kevin Peter McCabe (Los Alamos, New Mexico)
ABSTRACT Fabric-based computing systems and methods are disclosed. A fabric-based computing system can include a polymorphous computing fabric that can be customized on a per application basis and a host processor in communication with said polymorphous computing fabric. The polymorphous computing fabric includes a cellular architecture that can be highly parameterized to enable a customized synthesis of fabric instances for a variety of enhanced application performances thereof. A global memory concept can also be included that provides the host processor random access to all variables and instructions associated with the polymorphous computing fabric.
FILED Monday, March 10, 2003
APPL NO 10/383780
ART UNIT 2183 — Computer Architecture and I/O
CURRENT CPC
Electrical computers and digital processing systems: Processing architectures and instruction processing
712/15
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873843 Coteus et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Paul W. Coteus (Yorktown Heights, New York);  Todd Takken (Brewster, New York)
ABSTRACT A memory system is disclosed which is comprised of a memory controller and addressable memory devices such as DRAMs. The invention provides a programmable register to control the high vs. low drive state of each bit of a memory system address and control bus during periods of bus inactivity. In this way, termination voltage supply current can be minimized, while permitting selected bus bits to be driven to a required state. This minimizes termination power dissipation while not affecting memory system performance. The technique can be extended to work for other high-speed busses as well.
FILED Tuesday, June 26, 2007
APPL NO 11/768552
ART UNIT 2116 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electrical computers and digital processing systems: Support
713/300
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 07871682 Catella
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) Luke A. Catella (Plain View, Virginia)
ABSTRACT A composite laminate material is supported during the roll press processing thereof by an assembly having: first and second perforated films disposed adjacent to first and second opposing surfaces of a mixture of uncured resin and fibers defining the composite laminate material, a gas permeable encasement surrounding the mixture and the first and second films, a gas impervious envelope sealed about the gas permeable encasement, and first and second rigid plates clamped about the gas impervious envelope.
FILED Thursday, September 23, 2004
APPL NO 10/956520
ART UNIT 1782 — Miscellaneous Articles, Stock Material
CURRENT CPC
Stock material or miscellaneous articles
428/35.200
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07871944 Sanders et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S)
ASSIGNEE(S) United Technologies Corporation (Hartford, Connecticut)
INVENTOR(S) Stuart A. Sanders (Palm Beach Gardens, Florida);  Imelda P. Smyth (North Palm Beach, Florida)
ABSTRACT A process for applying an interface coating includes the step of applying an interface coating material upon at least one surface of a fiber-based substrate. The interface coating material may be composed of a sizing agent, a ceramic powder and optionally at least one of the following agents: a dispersing agent, a deflocculating agent or a surface wetting agent.
FILED Tuesday, August 08, 2006
APPL NO 11/500859
ART UNIT 1786 — Miscellaneous Articles, Stock Material
CURRENT CPC
Fabric
442/59
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872750 Wrbanek et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) John D. Wrbanek (Sheffield Village, Ohio);  Gustave C. Fralick (Middleburg Heights, Ohio);  Susan Y. Wrbanek (Sheffield Village, Ohio)
ABSTRACT A particle detector is provided, the particle detector including a spherical Cherenkov detector, and at least one pair of detector stacks. In an embodiment of the invention, the Cherenkov detector includes a sphere of ultraviolet transparent material, coated by an ultraviolet reflecting material that has at least one open port. The Cherenkov detector further includes at least one photodetector configured to detect ultraviolet light emitted from a particle within the sphere. In an embodiment of the invention, each detector stack includes one or more detectors configured to detect a particle traversing the sphere.
FILED Tuesday, September 30, 2008
APPL NO 12/285173
ART UNIT 2877 — Optics
CURRENT CPC
Optics: Measuring and testing
356/336
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873181 Maluf
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) A. David Maluf (Mountain View, California)
ABSTRACT Method and system for enhancing or extending visual representation of a selected region of a visual image, where visual representation is interfered with or distorted, by supplementing a visual signal with at least one audio signal having one or more audio signal parameters that represent one or more visual image parameters, such as vertical and/or horizontal location of the region; region brightness; dominant wavelength range of the region; change in a parameter value that characterizes the visual image, with respect to a reference parameter value; and time rate of change in a parameter value that characterizes the visual image. Region dimensions can be changed to emphasize change with time of a visual image parameter.
FILED Thursday, September 21, 2006
APPL NO 11/525600
ART UNIT 2624 — Selective Visual Display Systems
CURRENT CPC
Image analysis
382/100
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 07871794 Knapp et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Kurtis G. Knapp (Stanford, California);  James Robert Swarts (Menlo Park, California)
ABSTRACT Compositions and methods are provided for the enhanced in vitro synthesis of active polypeptides containing disulfide bonds. In certain embodiments of the invention, the reaction mix includes a biological extract derived from a bacterial cell in which the glutathione reductase gene has been inactivated, which is pre-treated with a low concentration of a sulfhydryl inactivating agent.
FILED Friday, January 18, 2008
APPL NO 12/016763
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/68.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872977 De et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S)
ASSIGNEE(S) New Jersey Institute of Technology (Newark, New Jersey)
INVENTOR(S) Swades De (New Delhi, India);  Komlan Egoh (Springfield Gardens, New York)
ABSTRACT A generalized multi-parameter mapping function aggregates decision criteria into a single virtual criterion to rank the potential relay candidates. Optimal rules for next hop relay as applicable to both transmitter-side selection and receiver-side election based forwarding schemes are also provided. Examples of network performance based on two optimization criteria include one-hop progress (greediness) and packet success rate (link quality). A suitable mapping function trades off the greediness for link quality. Simulation information is provided that indicates that the implementation according to the mapping function outperforms the reported transmitter-side link-aware forwarding schemes.
FILED Wednesday, June 04, 2008
APPL NO 12/132860
ART UNIT 2463 — Multiplex and VoIP
CURRENT CPC
Multiplex communications
370/238
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873727 Pal et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S)
ASSIGNEE(S) Board of Regents, The University of Texas Systems (Austin, Texas)
INVENTOR(S) Sourav Pal (Arlington, Texas);  Sumantra Kundu (Arlington, Texas);  Kalyan Basu (Arlington, Texas);  Sajal Das (Denton, Texas)
ABSTRACT A system and computer program for evaluating in real-time streaming multimedia quality. The system including a multimedia server connected to a multimedia source and a remote client in communication with the multimedia server over a network. The multimedia server is configured to receive multimedia content from the multimedia source and to transmit the multimedia content as a multimedia stream. The multimedia stream includes a plurality of audio frames and a plurality of video frames. The remote client is configured to establish a multimedia session with the multimedia server, receive the multimedia stream via the multimedia session, monitor the media quality of the multimedia stream, and passively compute a subjective quality of the multimedia stream.
FILED Thursday, March 13, 2008
APPL NO 12/048029
ART UNIT 2454 — Computer Networks
CURRENT CPC
Electrical computers and digital processing systems: Multicomputer data transferring
79/224
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 07872473 Kitching et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Secretary of Commerce, the National Institute of Standards and Technology (Washington, District of Columbia)
INVENTOR(S) John Kitching (Boulder, Colorado);  Elizabeth A. Donley (Boulder, Colorado);  Eleanor Hodby (Boulder, Colorado);  Andrei Shkel (Irvine, California);  Erik Jesper Eklund (Costa Mesa, California)
ABSTRACT An atomic magnetometer that simultaneously achieves high sensitivity, simple fabrication and small size. This design is based on a diverging (or converging) beam of light that passes through an alkali atom vapor cell and that contains a distribution of beam propagation vectors. The existence of more than one propagation direction permits longitudinal optical pumping of atomic system and simultaneous detection of the transverse atomic polarization. The design could be implemented with a micro machined alkali vapor cell and light from a single semiconductor laser. A small modification to the cell contents and excitation geometry allows for use as a gyroscope.
FILED Wednesday, August 06, 2008
APPL NO 12/186690
ART UNIT 2831 — Electrical Circuits and Systems
CURRENT CPC
Electricity: Measuring and testing
324/305
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07873969 Rausch
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S)
ASSIGNEE(S) Seagate Technology LLC (Scotts Valley, California)
INVENTOR(S) Tim Rausch (Gibsonia, Pennsylvania)
ABSTRACT A transducer assembly for a data storage system comprises a first transducer for directing electromagnetic radiation onto a storage medium adjacent to a write pole, and a second transducer for directing electromagnetic radiation onto a storage medium adjacent to a read sensor. A data storage apparatus that includes the transducer assembly is also included.
FILED Wednesday, June 30, 2004
APPL NO 10/881609
ART UNIT 2627 — Selective Visual Display Systems
CURRENT CPC
Dynamic optical information storage or retrieval
720/659
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 07871996 Weinberg et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S)
ASSIGNEE(S) The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Joe Brice Weinberg (Durham, North Carolina);  Dipak Kumar Ghosh (Durham, North Carolina)
ABSTRACT The present invention provides methods of inhibiting nitric oxide synthase (NOS) using corrin derivatives that bind NOS but do not bind NO. It also provides methods of inhibiting NOS in vivo by administering corrin derivatives, and methods of treating diseases and medical conditions using this inhibition of NOS.
FILED Friday, September 28, 2007
APPL NO 11/904747
ART UNIT 1614 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/186
VIEW PATENT @ USPTO:  Full Text   PDF 
US 07872048 Simard
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S)
ASSIGNEE(S) University of Maryland, Baltimore (Baltimore, Maryland)
INVENTOR(S) J. Marc Simard (Baltimore, Maryland)
ABSTRACT The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NCCa-ATP channel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
FILED Friday, September 16, 2005
APPL NO 11/229236
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/592
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, January 18, 2011.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2011/fedinvent-patents-20110118.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital